Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
20.5%
% of WDNA's 91 holdings also in SYNB
51.4%
% of SYNB's 36 holdings also in WDNA
Overlap by Weight
Sector Drift (WDNA minus SYNB)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in WDNA |
Weight in SYNB |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 2.1% | 3.7% | 2.1% | |
TWIST BIOSCIENCE CORP. | 4.3% | 2.0% | 2.0% | |
VERTEX PHARMACEUTICALS INC | 1.6% | 1.5% | 1.5% | |
REGENERON PHARMACEUTICALS | 1.4% | 4.2% | 1.4% | |
DANAHER CORP | 1.4% | 7.6% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
WDNA Overweight Relative to SYNB
NOVOZYMES A/S-B SHARES | 2.7% | |
BLUEPRINT MEDICINES CORP. | 2.6% | |
GERON CORP | 2.5% | |
AGIOS PHARMACEUTICALS INC | 2.4% | |
TWIST BIOSCIENCE CORP. | 2.3% | |
FATE THERAPEUTICS INC | 2.2% | |
NATERA INC | 2.2% | |
VERICEL CORPORATION | 2.1% | |
IOVANCE BIOTHERAPEUTICS INC | 1.7% | |
SAREPTA THERAPEUTICS INC | 1.7% |
WDNA Underweight Relative to SYNB
NVIDIA CORP | -7.0% | |
THERMO FISHER SCIENTIFIC INC | -6.7% | |
DANAHER CORP | -6.2% | |
BIO-RAD LABORATORIES-CL A | -5.1% | |
ALPHABET INC. CLASS A | -5.0% | |
NOVOZYMES A/S-UNSPONS ADR | -4.7% | |
ABBVIE INC | -4.3% | |
ASCENDIS PHARMA A/S | -3.5% | |
CORTEVA INC | -3.4% | |
AVANTOR, INC. | -3.0% |